Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. logo

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GU5)

Market Open
11 Aug, 06:02
XFRA XFRA
1. 69
0
0%
2.81B Market Cap
8.23 P/E Ratio
1.6% Div Yield
300 Volume
0 Eps
1.69
Previous Close
Add Transaction
Day Range
1.69 1.69
Year Range
1.55 2.3
Want to track GU5 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GU5) Statistics

Valuation metrics

Market Cap 2.81B
Enterprise value 1.42B
Trailing P/E (ttm) 7.52
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.04
Price/Book (mrq) 0.56
Enterprise Value/Revenue 0.14
Enterprise Value/EBITDA 2.92

Overview

Shares outstanding 1.63B
Float 876.66M
Shares short -
% Held by insiders -
% Held by institutions 0.21%
Average volume (10 days) 120
Average volume (90 days) 153

Price summary

52-Week low 1.55
52-Week high 2.3
Beta 0.28
50-Day moving average 1.85
200-Day moving average 1.97

Dividends and splits

Forward annual dividend rate 0.19
Forward annual dividend yield 0.1116%
Trailing annual dividend rate 0.05
Trailing annual dividend yield 0.0279%
5-Year annual dividend yield 4.41%
Payout ratio 0.44
Dividend Date 17 Jul 2026
Ex-Dividend Date 12 Jun 2026
Last split factor 10,031:10,000
Last split Date 28 Jan 2014

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.04%
Operating margin 0.09%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.07%

Income Statement

Revenue (ttm) 9.9B
Revenue per share (ttm) 48.26
Quarterly revenue growth (yoy) 0.04%
Gross profit (ttm) 1.59B
EBITDA 5.12B
Net income to common (ttm) 371.61M
Diluted EPS (ttm) 0.23
Quarterly earnings growth (yoy) -0.02%

Balance Sheet

Total cash (mrq) 1.56B
Total cash per share (mrq) 7.58
Total debt (mrq) 2.33B
Total Debt/Equity (mrq) 44.04
Current ratio (mrq) 1.6%
Book value per share (mrq) 3.07

Cash Flow

Cash flow statement 182.58M
Levered free cash flow (LFCF) -1.35B